-
ASMB Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Assembly Biosciences (ASMB)
Company Profile
Quarter (USD) | Sep 24 | Sep 23 | Jun 23 | Mar 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 28.45 mm | 28.45 mm | 28.45 mm | 28.45 mm | 28.45 mm | |
Cash burn (monthly) | (no burn) | 2.00 mm | 3.65 mm | 5.25 mm | 4.24 mm | |
Cash used (since last report) | n/a | 5.63 mm | 10.29 mm | 14.81 mm | 11.96 mm | |
Cash remaining | n/a | 22.82 mm | 18.16 mm | 13.64 mm | 16.50 mm | |
Runway (months of cash) | n/a | 11.4 | 5.0 | 2.6 | 3.9 |
13F holders | Current |
---|---|
Total holders | 13 |
Opened positions | 5 |
Closed positions | 15 |
Increased positions | 2 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 9.16 bn |
Total shares | 671.66 k |
Total puts | 0.00 |
Total calls | 48.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Armistice Capital | 468.00 k | $6.42 bn |
Millennium Management | 123.46 k | $1.69 bn |
Susquehanna International | 17.40 k | $238.73 mm |
Bridgeway Capital Management | 14.50 k | $198.94 mm |
STT State Street | 12.81 k | $175.74 mm |
Citadel Advisors | 12.75 k | $174.88 mm |
Marquette Asset Management | 9.02 k | $123.70 mm |
Amundi | 7.93 k | $96.40 mm |
BCS Barclays | 2.99 k | $41.00 k |
MS Morgan Stanley | 2.56 k | $35.15 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Dec 24 | Gilead Sciences | Common Stock | Buy | Acquire P | No | No | 21.37 | 940,499 | 20.10 mm | 2,209,471 |
25 Nov 24 | Alexander Schornstein | Common Stock | Buy | Acquire P | No | No | 14.85 | 5,000 | 74.25 k | 728,113 |
25 Nov 24 | Alexander Schornstein | Common Stock | Buy | Acquire P | No | No | 0 | 2,976 | 0.00 | 723,113 |
22 Nov 24 | Alexander Schornstein | Common Stock | Buy | Acquire P | No | No | 14.8675 | 17,024 | 253.10 k | 720,137 |
18 Nov 24 | Nicole S White | Common Stock | Sell | Dispose S | No | No | 16.29 | 40 | 651.60 | 11,871 |
8 Oct 24 | Alexander Schornstein | Common Stock | Buy | Acquire P | No | No | 14.58 | 10,000 | 145.80 k | 703,113 |
3 Oct 24 | Nicole S White | Common Stock | Sell | Dispose S | No | No | 14.81 | 157 | 2.33 k | 11,911 |